AstraZeneca has said it expects to have a new version of its COVID-19 vaccine ready for use for mid or late 2021 to respond to concerns about emerging variants that may be more transmissible or resistant to existing vaccines.
Will Canada have access to this updated vaccine under the terms of our existing bilateral supply agreement with AstraZeneca?